Allergic contact dermatitis due to drugs in contact with skin
ICD-10 L23.3 is a billable code used to indicate a diagnosis of allergic contact dermatitis due to drugs in contact with skin.
Allergic contact dermatitis due to drugs in contact with the skin is a hypersensitivity reaction that occurs when the skin comes into contact with a specific allergen, in this case, a drug. Clinically, patients may present with erythema, pruritus, and vesicular lesions at the site of contact, which can progress to oozing, crusting, and scaling. The anatomy involved primarily includes the epidermis and dermis, where the immune response is triggered by sensitized T-cells reacting to the drug. Disease progression can vary, with acute reactions typically resolving within weeks if the offending agent is removed, while chronic cases may lead to lichenification and persistent dermatitis. Diagnostic considerations include a thorough patient history to identify potential allergens, patch testing to confirm the specific drug causing the reaction, and ruling out other dermatological conditions such as irritant contact dermatitis or atopic dermatitis. Accurate diagnosis is crucial for effective management and prevention of future reactions.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L23.3 specifically covers allergic contact dermatitis resulting from exposure to drugs, including topical medications, systemic drugs that may cause skin reactions, and any drug-related allergens that lead to dermatitis.
L23.3 should be used when the dermatitis is specifically due to a drug allergen, as opposed to other allergens such as plants or metals, which would fall under different L23 codes.
Documentation should include a detailed patient history of drug exposure, clinical findings consistent with allergic contact dermatitis, results from patch testing, and any previous reactions to the drug in question.
